South Africa: Consumerism And Healthcare

Last Updated: 7 March 2012
Article by Neil Kirby

It is trite that Healthcare in South Africa is highly regulated by a number of statutes. These statutes are primarily designed to be consumer orientated. The Medical Schemes Act No. 131 of 1998, as amended ("the MSA") and the Medicines and Related Substances Act No. 101 of 1965, as amended ("the Medicines Act") are good examples. In both of these statutes, the issue of consumer rights stands at the forefront of what these statutes are designed to achieve. This is evident from their objectives. The MSA provides in sections 7(a) and (d) that the functions of the Council for Medical Schemes shall be to "protect the interest of the beneficiaries at all times ... investigate complaints and settle disputes in relation to the affairs of medical schemes as provided for in this Act". The Medicines Act states that "[i]n determining whether or not the registration or the availability of a medicine is in the public interest, regard shall be had only to the safety, quality and therapeutic efficacy thereof in relation to its effect on the health of man or any animal, as the case may be."

Objectives of the CPA

The consumeristic nature of both the MSA and the Medicines Act is now to be tested against the provisions of the CPA. This is because the CPA is designed exclusively to promote the rights of South African consumers. The CPA's objectives deal with various types and classes of consumers. Therefore, the CPA is arguably designed to protect the rights of the consumer in all instances where there is a transaction as this term is defined in the CPA.

The objectives of the CPA are set out in section 3(1):

"The purposes of this Act are to promote and advance the social and economic welfare of consumers in South Africa by –

(a) establishing a legal framework for the achievement and maintenance of a consumer market that is fair, accessible, efficient, sustainable and responsible for the benefits of consumers generally;

(b) reducing and ameliorating any disadvantages experienced in accessing any supply of goods or services by consumers –

  1. who are low-income persons or persons comprising low-income communities;
  2. who live in remote, isolated or low-density population areas or communities;
  3. who are minors, seniors or other similarly vulnerable consumers; or
  4. whose ability to read and comprehend any advertisement, agreement, mark, instruction, label, warning, notice or other visual representations limit by reason of low literacy, vision impairment or limited fluency in a language in which the representation is produced, published or presented;

(c) promoting fair business practices;

(d) protecting consumers from –

  1. unconscionable, unfair, unreasonable, unjust or otherwise improper trade practices; and
  2. deceptive, misleading, unfair or fraudulent conduct;

(e) improving consumer awareness and information and encouraging responsible and informed consumer choice and behaviour;

(f) promoting consumer confidence, empowerment, and the development of a culture of consumer responsibility, through individual and group education, vigilance, advocacy and activism;

(g) providing for a consistent, accessible and efficient system of consensual resolution of disputes arising from consumer transactions; and

(h) providing for an accessible, consistent, harmonise, effective and efficient system of redress for consumers."

The provision of a healthcare service to a patient in exchange for remuneration and an expected positive outcome would fall within this scope and ambit of the definition of the term "transaction" in the CPA. Therefore, on the face of it, the CPA applies to healthcarerelated transactions. Accordingly, this brings into sharp focus the manner in which one would apply the CPA in instances where a healthcare related transaction occurs.

Healthcare related transactions

For purposes of this paper, a healthcare related transaction includes the provision of a hospital service, an emergency service, and an ambulance service or a consultation or a related healthcare service that has as its desired outcome the improvement of the health of the patient. In each of these instances, the transactions are primarily controlled by healthcare legislation on the basis that:

  • the healthcare service is to be provided by a duly qualified healthcare provider and in accordance with the obligations imposed upon the healthcare provider, both ethically and legally, to provide the service correctly and without harming the patient. Provisions of such legislation as the Allied Health Professions Act No. 63 of 1982, as amended and the Health Professions Act No. 56 of 1974 as amended or the HPA, all find relevance to the transaction that occurs;
  • the sale of medicines equally is controlled by the Pharmacy Act No. 53 of 1974, as amended and the Medicines Act, which require that medicines be sold in a particular manner by a person duly authorised in law to dispense such medicines;
  • the provision of private medical scheme cover is also dealt with exclusively in the MSA and the transaction that occurs is required to comply with the provisions of this Act, which would include the rules of a particular medical scheme;
  • other pieces of healthcare-related legislation deal with the manner in which hospital services are provided and how healthcare services in general are to be provided including such issues as informed consent, the consent of minors and the consent of vulnerable persons – all dealt with in the National Health Act No. 61 of 2003 ("the NHA").

In so far as healthcare services have been provided to date in terms of the existing statutory matrix of applicable healthcare legislation, the question is whether or not the provision of those services is, in accordance with that healthcare matrix, sufficient to promote and protect consumer rights. This question arises primarily due to the directive contained in section 2(9) of the CPA about how one is to interpret the CPA when it is interacting with an existing piece of legislation. The general principle is that the CPA will apply in circumstances where it does a better job, through its application, of advancing and protecting consumer rights than the piece of legislation with which it is being compared. This is not a self-evident comparison as one needs carefully to understand not only the provisions of the CPA in so far as they protect consumer rights, but whether or not arguably they do so in a better way than older pieces of legislation including existing provisions of healthcare legislation.

Consumer rights, statutory tribunal and alternative dispute resolution

On the face of it, the CPA contains a number of consumer rights that are not expressly found in other pieces of healthcare legislation. I say "expressly" as the healthcare legislation to which I have referred is not necessarily as dedicated and as focused on consumer rights as the CPA. Therefore, the more pronounced and clearer rights contained in the CPA may very well trump the manner in which existing healthcare legislation endeavours to promote, advance and provide for consumer rights. The comparison that must occur would conceivably have to determine the substantive nature of the consumer right that is being advanced and protected. Therefore, one would be required to draw comparisons between, for example, the National Patients' Rights Charter, which appears as part of the publications published by the Health Professions Council of South Africa (HPCSA), and the consumer rights contained in the CPA.

Therefore, a consumer's right to information about a product, service or information that is provided in a clear, plain and understandable way would need to be compared to rights contained in the NHA concerning the manner in which informed consent must be provided to a patient prior to that patient receiving treatment. In so far as the informed consent provisions of the NHA fall short of the consumer rights contained in the CPA, then conceivably, the CPA would apply. In such circumstances the CPA would impose consumer rights into the healthcare transaction and require a new evaluation of that transaction on that basis - healthcare legislation aside.

The provisions contained in healthcare legislation that create statutory tribunals for the resolution of disputes between consumers and healthcare providers, most notably, those contained in section 47 of the MSA and the dispute resolution mechanisms contained in the HPA, which allow consumers to refer disputes about healthcare practitioners to the HPCSA, would also need to be evaluated on the basis of whether or not those tribunals are effective for purposes of enforcing consumer rights. The CPA, as part of its dispute resolution mechanism processes, recognises the ability of accredited institutions to resolve consumer complaints with reference to the provisions contained in the CPA. However, in order to resolve such disputes, with reference to the provisions of the CPA, the dispute resolution tribunal in question must be accredited by the Minister of Trade and Industry in terms of the CPA. I am not aware of any such accreditations having occurred to date for any of the tribunals that are currently functioning within the healthcare arena.

The provision of alternative dispute resolution mechanisms is an important part of the CPA. The CPA is designed to be accessible to the ordinary man and woman in the street. Therefore, its provisions allow for complaints to be lodged, without the intervention necessarily of the legal fraternity, directly by the consumer with such bodies as the National Consumer Commission or an accredited Ombudsperson who is authorised to deal with such disputes. Therefore, existing dispute resolution mechanisms also need to be evaluated in relation to their effectiveness to resolve consumer disputes between patients and healthcare providers with reference to the provisions contained in the CPA.

The power and influence of the CPA should thus not be underestimated. In accordance with the provisions of South African law, conflicts between pieces of legislation are resolved in accordance with the principles of the interpretation of statutes. One of these principles states that more recent legislation trumps the provisions of older legislation where there may be a conflict. The fact that the CPA was enacted in 2010 and its citation refers to the fact that it was proposed in 2008, indicates that it will trump the majority of existing healthcare legislation – in so far as I am not aware of any healthcare legislation that was enacted after the CPA came into effect, even in circumstances where the CPA was brought into force gradually and then finally on 1 April 2010.

Interaction in the UK

These are uncertain times in relation to the interaction between the CPA and its creation of consumer rights and interaction with existing healthcare legislation. The interaction between healthcare legislation and consumer protection legislation has already received attention in the United Kingdom which possesses similar legislation to that of the CPA. This interaction is examined in a publication by Margaret Brazier entitled Medicine, Patients and the Law (third edition) at page 198.

The examination occurs most usefully in relation to the imposition of product liability principles in respect of the sale of medicines and medical devices. Currently, in South African law, medicines are controlled in our marketplace – in respect of their distribution, manufacture, sale and dispensing – in terms of the Medicines Act and the Pharmacy Act. Medical devices have, to date, received less attention but regulations are pending for purposes of controlling medical devices.

In relation to the imposition of consumer protection principles in ordinary product liability law, with reference to a special commodity such as medicines and medical devices, Brazier argues that there is a complex interaction between the sale of medicines that cause injury to the person taking them and consumer protection legislation.

The interaction is complex to a point of deciding whether or not medicines fall within the scope and ambit of the English consumer protection legislation but nevertheless there is uncertainty on whether or not medicines would fall outside of such legislation. The prevailing view being that the legislation, in the form of the English Consumer Protection Act, applies to such goods. In this regard, Brazier cites the decision of Abouzaid v Mothercare Ltd in which a 12 year old boy had his eye damaged as a result of a strap slipping from his grasp and hitting him in the left eye after endeavouring to clip a sleeping bag to a push chair by passing elasticised straps around the back of the chair with a metal buckle. Brazier states "[t]he Court of Appeal found that the product was defective. There was a failure to provide instructions and the design of the product was unsafe because it could not be secured without risk. Consumers would properly expect that such a product could be used without that degree of risk. Relatively minor alterations in the design would eliminate that risk. The Mothercare judgment can be applied to make two key points about liability for drugs. (1) Instructions about the use of, and warnings concerning possible adverse effects of, drugs are crucial. Failure to warn of a known risk will, as argued earlier, render a drug defective. (2) Common sense will play its part in determining what 'people generally' may expect from a product." (at pages 209 to 210).

This point was then enforced in a further judgment in Richardson v LRC Products Ltd in which the plaintiff sued due to a defect in a condom, which caused her to become pregnant. Usefully, Brazier states the problem in the following assessment of the interaction primarily between the sale of medicines and consumer protection legislation: "Returning to drug-induced harm, consider the following examples in the light of the... cases. You purchase Ibuprofen in a supermarket. The packet clearly warns you not to take the medicine if you suffer from asthma. You ignore that warning and, despite your asthma, take several tablets. An acute attack of asthma lands you in hospital. Is that pack of Ibuprofen defective? You are prescribed a cream to cure acne. No warning accompanies the product. The cream causes the eruption of a rash all over your body. Evidence emerges that the product will produce just such an allergic reaction in about 2% of female users if they use the cream during pregnancy. Neither you nor your GP was aware you were pregnant at the time. Is the product defective?" (at page 210).


hat remains evident is there is a complex interaction between product liability and medicines and medical devices in South African law. The CPA also contains strict liability provisions for products that are unsafe or cause harm to consumers. Therefore, manufacturers, distributors, dispensers and anyone within the healthcare profession who recommends the use of a product, which ultimately causes the patient harm, may very well find themselves on the end of a product liability claim. A complex legal debate will then occur not only on the basis of who knew about what, but whether or not there was in fact a causal link between the harm suffered by the patient and the use and sale of the medicine in question. The twist in the introduction of the CPA is that the causal connection is something that must be approved by the defendant as opposed to the plaintiff along with other aspects concerning negligence. This is the effect of strict liability, which shifts the burden of proving that there was no negligence to the defendant as opposed to, as is traditionally the case, the plaintiff who is required to prove his or her case in court.

The effect of a comparison between legislation such as the MSA or the NHA and the CPA does reveal an interesting correlation between the rights contained in the CPA and those already contained in existing legislation. Such a comparison, albeit on very broad principles, is provided.

The difficulty remains, however, whether or not a patient will pursue his or her rights under existing healthcare legislation and nevertheless enjoy additional rights to pursue claims, on a far easier litigation basis, due to the effects of strict liability in the CPA: in terms of his or her rights under the CPA. This is enhanced by directions in the CPA that require a judge or a court, when dealing with the application of the CPA for purposes of deciding a consumer complaint, to interpret the legislation before him or her or the contractual terms of the transaction, as the case may be, in such a way as to favour the consumer.

The actual interaction between the CPA and existing healthcare legislation may be resolved in so far as statutory bodies, which are primarily responsible for the control and application of their various statutes, such as the Council for Medical Schemes or the HPCSA, obtain an exemption from the CPA for them to conduct their affairs in accordance with provisions contained in their existing legislation and of which they are the wardens. Applications for such exemptions will have to be made directly to the Minister of Trade and Industry and a careful analysis undertaken in order to show that consumers are equally protected under the existing healthcare legislation as they are under the CPA. Whether or not such exemptions will in fact be provided, remains a matter of speculation. Currently, however, consumers are king in so far as they enjoy rights under the CPA and, conceivably, under existing healthcare legislation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.